Linked Life Data

8241298

Source:http://linkedlifedata.com/resource/pubmed/id/8241298

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1994-1-6
pubmed:abstractText
During the last years some medical centers have performed emergency treatment for intracranial thromboembolic occlusions by thrombolysis using streptokinase, urokinase, and recombinant tissue plasminogen activator intraarterially or intravenously. So far, it appears that the risk of intracranial hemorrhage with clinical deterioration is not increased by thrombolysis if thrombolysis is performed during the first 8 hours after symptom onset. Successful recanalization of occlusions in the anterior or posterior circulation is associated with a decrease of mortality and morbidity. Intraarterial application of the thrombolytic agent seems to be more effective than intravenous application. However, there is still a lack of controlled studies that could exclusively prove which thrombolytic agent and which mode of application is the most effective with regard to arterial recanalization and clinical outcome.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0939-267X
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
351-5
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
[Thrombolysis in acute cerebral ischemia].
pubmed:publicationType
Journal Article, English Abstract, Review